Zearalenone screening of human breast milk from the Naples area

The mycotoxin zearalenone exhibits estrogenic and anabolic properties in several animal species, humans included. Food contamination by zearalenone is caused either by direct contamination of grains, fruits, and their based-products or by “carry-over” of mycotoxins in animal tissues, milk, and eggs after intake of contaminated feedstuff. Now, a survey on zearalenone contamination in breast milk of healthy primiparous women living in the Naples countryside was conducted. From 47 healthy primiparous women, breast milk samples were collected within the first six weeks after delivery as well as clinical data of mother–newborn pairs. Breast milk analyses were performed with both competitive indirect enzyme-linked immunosorbent assay and high-performance liquid chromatography with fluorescence detection. At 36.9 ± 2.6 days after vaginal delivery, the mean zearalenone contents of the breast milk samples were 1.13 ± 0.34 µg/L. The zearalenone levels correlated with both mother weights before pregnancy (r = −0.506; P < 0.001) and at delivery (r = −0.351; P < 0.05). The present results indicate that breast milk may be contaminated with zearalenone.

[1]  V. Yusà,et al.  Evaluation of mycotoxins and their metabolites in human breast milk using liquid chromatography coupled to high resolution mass spectrometry. , 2014, Analytica chimica acta.

[2]  G. Saggese,et al.  Mycoestrogen pollution of Italian infant food. , 2011, The Journal of pediatrics.

[3]  G. Saggese,et al.  Oestrogenic mycotoxin exposures and precocious pubertal development. , 2010, International journal of andrology.

[4]  V. Meucci,et al.  Mycotoxin detection in infant formula milks in Italy , 2010, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[5]  L. Toms,et al.  Fourth WHO-coordinated survey of human milk for persistent organic pollutants , 2010 .

[6]  M. Abdel-Wahhab,et al.  Mycotoxins and child health: the need for health risk assessment. , 2009, International journal of hygiene and environmental health.

[7]  Jose Russo,et al.  Oral Exposure to Bisphenol A Increases Dimethylbenzanthracene-Induced Mammary Cancer in Rats , 2009, Environmental health perspectives.

[8]  M. Arendt Communicating human biomonitoring results to ensure policy coherence with public health recommendations: analysing breastmilk whilst protecting, promoting and supporting breastfeeding , 2008, Environmental health : a global access science source.

[9]  G. Saggese,et al.  High growth rate of girls with precocious puberty exposed to estrogenic mycotoxins. , 2008, The Journal of pediatrics.

[10]  G. Saggese,et al.  Chemical Biomarkers of Human Breast Milk Pollution , 2008, Biomarker insights.

[11]  F. Bianchi,et al.  Cluster analysis of mortality and malformations in the Provinces of Naples and Caserta (Campania Region). , 2008, Annali dell'Istituto superiore di sanita.

[12]  Juan Carlos Moltó,et al.  Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[13]  F. Bianchi,et al.  Cancer Mortality in an Area of Campania (Italy) Characterized by Multiple Toxic Dumping Sites , 2006, Annals of the New York Academy of Sciences.

[14]  A. Visconti,et al.  Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters. , 2005, Toxicology letters.

[15]  L. Zeise,et al.  Breast milk and lipid intake distributions for assessing cumulative exposure and risk , 2005, Journal of Exposure Analysis and Environmental Epidemiology.

[16]  Fabrizio Bianchi,et al.  Italian "Triangle of death". , 2004, The Lancet. Oncology.

[17]  K. Senior,et al.  Italian "Triangle of death" linked to waste crisis. , 2004, The Lancet. Oncology.

[18]  M. Breitenbach,et al.  Fungal allergy and pathogenicity , 2002 .

[19]  J. Thornton,et al.  Biomonitoring of Industrial Pollutants: Health and Policy Implications of the Chemical Body Burden , 2002, Public health reports.

[20]  W. Shier,et al.  Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. , 2001, Toxicon : official journal of the International Society on Toxinology.

[21]  T. Kuiper-Goodman Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenone. , 1990, Canadian journal of physiology and pharmacology.

[22]  P. Scott,et al.  Risk assessment of the mycotoxin zearalenone. , 1987, Regulatory toxicology and pharmacology : RTP.

[23]  S. Milani,et al.  Italian standards for crown-heel length and head circumference at birth. , 1987, Annals of human biology.

[24]  C. J. Mirocha,et al.  Comparative metabolism of zearalenone and transmission into bovine milk. , 1981, Food and cosmetics toxicology.

[25]  R. Siegfried [Fusarium toxins]. , 1977, Die Naturwissenschaften.